Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nayaab Khan"'
Autor:
Nayaab Khan, Lucas Laudermilk, Jalen Ware, Taylor Rosa, Kelly Mathews, Elaine Gay, George Amato, Rangan Maitra
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Metabolic syndrome (MetS) is a complex disorder that stems from the additive effects of multiple underlying causes such as obesity, insulin resistance, and chronic low-grade inflammation. The endocannabinoid system plays a central r
Retaliatory aggression is a rewarding behavior. Decisions about rewarding behaviors often involve an intertemporal bias, such that people prefer immediate rewards and discount delayed rewards. We integrated these literatures to test whether the delay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71b73bf6f66e336a6950bd234dbf63de
https://doi.org/10.31234/osf.io/wpfrs
https://doi.org/10.31234/osf.io/wpfrs
Autor:
Kipp Johnson, Jagat Narula, Benjamin Glicksberg, Khader Shameer, Farhan Chaudhry, Alexandre Yahi, Nayaab Khan, Letizia Amadori, Chayakrit Krittanawong, Ben Readhead, Ross Hagan, Christine Becker, Fayzan Chaudhry, Aparna Divaraniya, Milo Smith, Usman Baber, Li Li, Benjamin McCauley, Girish Nadkarni, Koon Yan Pak, Brian Gray, Deepak Kaji, Bethany Percha, Yuliya Vengrenyuk, Javed Suleman, Nicholas Tatonetti, Atul Butte, Artiom Petrov, Eloisa Arbustini, Chiara Giannarelli, Navneet Narula, William Strauss, Joel Dudley, Annapoorna Kini
Background. Current lipid-lowering drugs often leave significant residual risk for adverse outcomes. Identification of previously approved drugs for new indications, drug repurposing, may provide a cost effective alternative to de novo drug developin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad2561ef45f95e914c21259220acf6a
https://doi.org/10.21203/rs.3.rs-567817/v1
https://doi.org/10.21203/rs.3.rs-567817/v1